SCHEMBL1034628

SCHEMBL1034628

CCCc1c(CCC(=O)c2cc(C)c(O)cc2O)sc2cc(C(F)(F)F)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
RECQL P46063 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
MAPT P10636 5/20 0.32
LMNA P02545 1/20 0.32
XBP1 P17861 1/20 0.32
HIF1A Q16665 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
KDM4E B2RXH2 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031655 0.87 PPARD (0.43) FFAR4PPARGPPARA
SCHEMBL1035701 0.85 ESR1 (0.42) ALDH1A1HPGDTSHRHSD17B10MAPT
SCHEMBL1035702 0.81 IDH1 (0.36) HSD17B10HSD17B1HSD17B2MAPTLMNA
SCHEMBL1031656 0.80 MAPT (0.36) HSD17B1HSD17B2MAPTESR1PPARG
SCHEMBL1035265 0.79 ESR1 (0.35) HSD17B1HSD17B2GAAESR1
SCHEMBL1033815 0.77 PPARD (0.42) CYP1A2FFAR4PPARGPPARAL3MBTL1
SCHEMBL1035148 0.77 PPARD (0.41) FFAR4PPARGPPARA
SCHEMBL1081800 0.76 ESR1 (0.40) HSD17B1HSD17B2FFAR4ESR1PPARG
SCHEMBL1033328 0.75 PPARD (0.36) HSD17B1HSD17B2MEN1KMT2ACYP3A4
SCHEMBL1035264 0.75 CYP1A1 (0.37) LMNABCL2L1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD ALDH1A1 657/4885HPGD 1154/4885ALOX15 938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.